The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.
|Original language||English (US)|
|Title of host publication||Clinical Dilemmas in Inflammatory Bowel Disease|
|Subtitle of host publication||New Challenges: Second Edition|
|Number of pages||4|
|State||Published - Jan 30 2012|
- Ulcerative colitis
ASJC Scopus subject areas